Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018

It is unclear how treatment advances impacted the population‐level survival of patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia (LPL/WM). Therefore, we assessed trends in first‐line therapy and relative survival (RS) among patients with LPL/WM diagnosed in the Netherlands betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaador, Karima, Kersten, Marie José, Visser, Otto, Brink, Mirian, Posthuma, Eduardus F. M., Minnema, Monique C., Vos, Josephine M. I., Dinmohamed, Avinash G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematological malignancy–Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292034/
https://www.ncbi.nlm.nih.gov/pubmed/34605017
http://dx.doi.org/10.1111/bjh.17856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292034/
https://www.ncbi.nlm.nih.gov/pubmed/34605017
http://dx.doi.org/10.1111/bjh.17856

Ejemplares similares